Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anti-cancer activity

Qiankun Chen,1 Ji Liu2 1Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China; 2Department of Anesthesia, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China Aim: The aim of this study was to prepare transfer...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chen Q, Liu J
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/fcbda67b6779471d9a4e4e075b6deab0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fcbda67b6779471d9a4e4e075b6deab0
record_format dspace
spelling oai:doaj.org-article:fcbda67b6779471d9a4e4e075b6deab02021-12-02T07:32:25ZTransferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anti-cancer activity1178-2013https://doaj.org/article/fcbda67b6779471d9a4e4e075b6deab02018-10-01T00:00:00Zhttps://www.dovepress.com/transferrin-and-folic-acid-co-modified-bufalin-loaded-nanoliposomes-pr-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Qiankun Chen,1 Ji Liu2 1Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China; 2Department of Anesthesia, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China Aim: The aim of this study was to prepare transferrin (Tf) and folic acid (FA) co-modified bufalin (BF) liposomes for lung cancer treatment.Method: In this study, (FA+Tf) BF-LPs were prepared using the high-pressure homogenization method.Results: The EE% and DL% of prepared LPs were 82.3% and 10.7%, respectively, and the mean diameter was 120.4 nm from three batches. In vitro release showed that the release of BF from (FA+Tf) BF-LPs was slow with burst effects at an early stage. In vitro cytotoxicity assay showed that (FA+Tf) BF-LPs had a superior antiproliferative effect on A549 cells. An in vivo imaging study indicated that (FA+Tf) BF-LPs had obvious targeting characteristics on subcutaneous tumor, with the potential to actively deliver drugs to tumor tissues. In terms of the in vivo antitumor activity, (FA+Tf) BF-LPs treated mice showed a significantly suppressed tumor growth and no systemic toxicity in the body.Conclusion: Through this study, it was found that the Tf and FA co-modified BF could be a very promising lung target preparation. Keywords: transferrin, folic acid, liposomes, bufalin, in vivo imaging, antitumor activityChen QLiu JDove Medical Pressarticletransferrinfolic acidliposomesbufalinin vivo imaginganti-tumor activityMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 6009-6018 (2018)
institution DOAJ
collection DOAJ
language EN
topic transferrin
folic acid
liposomes
bufalin
in vivo imaging
anti-tumor activity
Medicine (General)
R5-920
spellingShingle transferrin
folic acid
liposomes
bufalin
in vivo imaging
anti-tumor activity
Medicine (General)
R5-920
Chen Q
Liu J
Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anti-cancer activity
description Qiankun Chen,1 Ji Liu2 1Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China; 2Department of Anesthesia, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China Aim: The aim of this study was to prepare transferrin (Tf) and folic acid (FA) co-modified bufalin (BF) liposomes for lung cancer treatment.Method: In this study, (FA+Tf) BF-LPs were prepared using the high-pressure homogenization method.Results: The EE% and DL% of prepared LPs were 82.3% and 10.7%, respectively, and the mean diameter was 120.4 nm from three batches. In vitro release showed that the release of BF from (FA+Tf) BF-LPs was slow with burst effects at an early stage. In vitro cytotoxicity assay showed that (FA+Tf) BF-LPs had a superior antiproliferative effect on A549 cells. An in vivo imaging study indicated that (FA+Tf) BF-LPs had obvious targeting characteristics on subcutaneous tumor, with the potential to actively deliver drugs to tumor tissues. In terms of the in vivo antitumor activity, (FA+Tf) BF-LPs treated mice showed a significantly suppressed tumor growth and no systemic toxicity in the body.Conclusion: Through this study, it was found that the Tf and FA co-modified BF could be a very promising lung target preparation. Keywords: transferrin, folic acid, liposomes, bufalin, in vivo imaging, antitumor activity
format article
author Chen Q
Liu J
author_facet Chen Q
Liu J
author_sort Chen Q
title Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anti-cancer activity
title_short Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anti-cancer activity
title_full Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anti-cancer activity
title_fullStr Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anti-cancer activity
title_full_unstemmed Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anti-cancer activity
title_sort transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anti-cancer activity
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/fcbda67b6779471d9a4e4e075b6deab0
work_keys_str_mv AT chenq transferrinandfolicacidcomodifiedbufalinloadednanoliposomespreparationcharacterizationandapplicationinanticanceractivity
AT liuj transferrinandfolicacidcomodifiedbufalinloadednanoliposomespreparationcharacterizationandapplicationinanticanceractivity
_version_ 1718399378667864064